Globus Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Globus Medical and other ETFs, options, and stocks.

About GMED

Globus Medical, Inc. operates as a medical device company that develops and commercializes healthcare solutions. The firm engages in developing products that promote healing in patients with musculoskeletal disorders. 

CEO
Keith W. Pfeil
CEOKeith W. Pfeil
Employees
5,300
Employees5,300
Headquarters
Audubon, Pennsylvania
HeadquartersAudubon, Pennsylvania
Founded
2003
Founded2003
Employees
5,300
Employees5,300

GMED Key Statistics

Market cap
11.90B
Market cap11.90B
Price-Earnings ratio
28.76
Price-Earnings ratio28.76
Dividend yield
Dividend yield
Average volume
1.73M
Average volume1.73M
High today
$90.23
High today$90.23
Low today
$88.40
Low today$88.40
Open price
$89.42
Open price$89.42
Volume
1.36M
Volume1.36M
52 Week high
$94.93
52 Week high$94.93
52 Week low
$51.79
52 Week low$51.79

Stock Snapshot

As of today, Globus Medical(GMED) shares are valued at $88.42. The company's market cap stands at 11.9B, with a P/E ratio of 28.76.

On 2025-12-09, Globus Medical(GMED) stock moved within a range of $88.40 to $90.23. With shares now at $88.42, the stock is trading +0.0% above its intraday low and -2.0% below the session's peak.

Trading volume for Globus Medical(GMED) stock has reached 1.36M, versus its average volume of 1.73M.

The stock's 52-week range extends from a low of $51.79 to a high of $94.93.

The stock's 52-week range extends from a low of $51.79 to a high of $94.93.

GMED News

Simply Wall St 4d
How Investors Are Reacting To Globus Medical Earnings Beat, Raised Outlook and CFO Share Sale

On December 1, 2025, Globus Medical’s CFO Kyle Kline sold 18,542 Class A shares for about US$1.66 million after the company reported third‑quarter earnings and...

How Investors Are Reacting To Globus Medical Earnings Beat, Raised Outlook and CFO Share Sale
Simply Wall St 6d
Globus Medical: Reassessing Valuation After Recent Share Price Momentum

Globus Medical (GMED) has quietly turned heads with a roughly 47% jump over the past month and about 51% over the past 3 months, as investors reassess its growt...

Globus Medical: Reassessing Valuation After Recent Share Price Momentum

Analyst ratings

60%

of 15 ratings
Buy
60%
Hold
33.3%
Sell
6.7%

People also own

Based on the portfolios of people who own GMED. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.